top of page

Bayer, DelSiTech partner to develop new drug delivery technology for ophthalmology

Bayer and DelSiTech have partnered to develop innovative drug delivery technology for ophthalmology.

The companies have signed a collaboration and technology licence agreement for the worldwide application of DelSiTech’s Silica Matrix drug delivery platform to a number of Bayer’s compounds in ophthalmology.

Click on this link for more information.


Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page